|  | Alleles |  | Genotypes | Recessive p-value |  | |||
---|---|---|---|---|---|---|---|---|---|
-592 (rs1800872) | n | A | C | p-Value | AA | AC | CC | AA vs. AC + CC | OR (95% CI) |
 PEX, n (%) | 114 | 130 (57.02) | 98 (42.98) | 0.39 | 16 (14) | 98 (86) | 0 (0) | 0.04 | 4.97 (4.45–21.08) |
 PEXG, n (%) | 118 | 128 (54.24) | 108 (45.76) | 0.68 | 10 (8.5) | 108 (91.5) | 0 (0) | 0.26 | NA |
 POAG, n (%) | 114 | 126 (55.26) | 102 (44.74) | 0.57 | 12 (10.5) | 102 (89.5) | 0 (0) | 0.14 | NA |
 Control, n (%) | 126 | 130 (51.59) | 122 (48.41) | Ref group | 4 (3.2) | 122 (96.8) | 0 (0) | Ref group | – |
-819 (rs1800871) | n | T | C | p-Value | TT | TC | CC | TT vs. TC + CC | OR (95% CI) |
 PEX, n (%) | 114 | 130 (57.02) | 98 (42.98) | 0.39 | 16 (14) | 98 (86) | 0 (0) | 0.004 | 10.12 (13.29–71.61) |
 PEXG, n (%) | 118 | 128 (54.24) | 108 (45.76) | 0.68 | 10 (8.5) | 108 (91.5) | 0 (0) | 0.03 | 5.74 (7.98–43.34) |
 POAG, n (%) | 114 | 126 (55.26) | 102 (44.74) | 0.57 | 12 (10.5) | 102 (89.5) | 0 (0) | 0.01 | 7.29 (9.89–53.53) |
 Control, n (%) | 126 | 126 (50) | 126 (50) | Ref group | 2 (1.6) | 122 (96.8) | 2 (1.6) | Ref group | – |
-1082 (rs1800896) | n | A | G | p-Value | AA | AG | GG | AA vs. AG + GG | OR (95% CI) |
 PEX, n (%) | 114 | 132 (57.89) | 96 (42.11) | 0.22 | 22 (19.3) | 88 (77.2) | 4 (3.5) | 0.02 | 7.29 (6.37–29.69) |
 PEXG, n (%) | 118 | 130 (55.08) | 106 (44.92) | 0.43 | 24 (20.3) | 82 (69.5) | 12 (10.2) | 0.002 | 7.79 (6.76–31.39) |
 POAG, n (%) | 114 | 130 (57.02) | 98 (42.98) | 0.28 | 24 (21.1) | 82 (71.9) | 8 (7) | 0.005 | 8.13 (7.06–32.82) |
 Control, n (%) | 126 | 126 (50) | 126 (50) | Ref group | 4 (3.2) | 118 (93.6) | 4 (3.2) | Ref group | – |